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INTRODUCTION 
 
Tumours of the salivary glands form a fascinating subject for the 
head and neck surgeons. The relative infrequency combined with 
considerable histologic and Behavioural diversity and their regional 
anatomic relationship make them unusually interesting and challenging. 
The parotid tumours are more so because of their intimate relationship to 
the facial nerve, the presence of intra and paraparotid lymph nodes, and 
presence of a lobe. 
 
Salivary gland tumours comprise less than 3 % of all neoplasms of 
head and neck and no more than 1 % of all neoplasms. Approximately      
80-85% of all salivary gland neoplasm occurs in the parotid gland. 
Although 80% of these are benign, earlier reports indicated a high 
recurrence rate after limited resection. This has led to a more aggressive 
approach to the treatment of these lesions in the recent years in the form 
of either subtotal or total conservative parotidectomy with excellent 
results. 
 
The successful treatment of these tumours involves understanding 
of diagnosis, surgical anatomy, histopathology, biological behaviour and 
appropriate uses of the various techniques and modalities of therapy. 
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The peculiar features of salivary gland tumours make it difficult for 
a single surgeon or institution to do meaningful prospective studies. In 
addition long term follow up is critical for many tumour types, but is 
lacking in most recent reports. Thus, much of our knowledge is based on 
retrospective studies, small series and short follow up. 
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REVIEW OF ANATOMY AND PATHOPHYSIOLOGY 
 
DEVELOPMENT OF PAROTID 
 The parotid gland arises from the epithelial of the mouth. The 
frequent finding of sebaceous glands in the parotid suggests an 
ectodermal origin. Parotid glands are the first salivary glands to appear. 
When the embryo is about 4-6 weeks of development, parotid appears as 
an epithelial ingrowth near the angle of the mouth on inner surface of 
either cheeks. As it grows backwards, towards the ramus of the mandible, 
it becomes a hollowed tube at this level, branches intensively into the 
primodial ducts and acinar cells. The tube persists as the parotid duct. 
Condensation of the mesenchyme surrounding the developing parotid 
gland occurs, later in embryonic life. So lymphnodes may become 
entrapped in the gland. The origin of myoephithelial cells is unknown. 
 
SURGICAL ANATOMY 
 The parotid is the largest salivary situated immediately inferior and 
anterior to the lower part of the ear. The gland is purely serous in nature. 
It forms an irregular, lobulated yellowish mass, lying below the external 
acoustic meatus, between the mandible and the sternomastoid muscle. It 
projects forward on the surface of the masseter, where a small part of it, 
 
9
usually more or less detached, lies between the zygomatic arch above and 
the parotid duct below. This is named the accessory parotid.   
 
 The investing layer of deep cervical fascia splits between the angle 
of the mandible and mastoid to enclose the parotid gland. 
 
 The parotid gland is like an inverted, flattened, three sided 
pyramid. The surfaces are a small superior surface, super antromedial and 
posteromedial surface. The lower part of the gland tapers to form a blunt 
apex. The superior surface is concave and is related to the external 
acoustic meatus and to the posterior surface of temporomandibular joint. 
Superficial temporal vessels and auriculotemporal nerve emerge out from 
the gland at this surface. 
 
  The superficial surface is covered with skin, superficial fascia, 
parotid fascia which is thick and adherent to the gland and a few deep 
parotid lymph nodes embedded in the gland. 
 
 The anteromedial surface is grooved by the posterior border of the 
ramus of the mandible. It covers the lateral aspect of the 
temporomandibular joint. The branches of the facial nerve emerge on the 
face from under cover of the anterior margin of this surface. 
 
10
 The posteromedial surface is moulded to the mastoid and the 
styloid process. Thus it is related to the sternomastoid, posterior belly of 
digastric, stylohyoid muscle and ligament, stylopharyngeus and the 
stylomandibular ligament. The external carotid artery grooves this surface 
before it enters the gland. The anteromedial and the posteromedial 
surfaces meet along a medial margin which may be in contact with the 
side wall of the pharynx. 
 
 The apex of the gland extends into the carotid triangle. The cervical 
branch of the facial nerve and the two divisions of the retromandibular 
vein emerge through it. 
 
 The parotid duct is 5 cm long. It crosses the masseter and at the 
anterior border of this muscle, it turns inwards, pierces the buccinator, 
runs deep to the mucosa and opens into the oral cavity opposite the upper 
second molar tooth. 
 
 Many authors feel that the parotid is a bilobed structure. The larger 
superficial segment of the gland which comprises 70-80% of the entire 
gland lies superficial to the faciovenous plane of patey and the similar 
deeper portion lies deep to it. 
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 The external carotid artery the gland through its posteromedial 
surface and divides into its terminal branches. 
 
 The facial nerve is associated with the parotid gland for an 
important part of its course during which it divides into its external 
branches. After it exits the stylomastoid foramen, it passes forwards 
around the neck of the condyle of the mandible and enters the parotid 
gland, passing superficial to the external carotid artery and the posterior 
facial vein. At this stage, the nerve usually divides into two main 
divisions the temperofacial and cervicofacial, these in turn subdivide into 
at least five main branches-temporal, zygomatic, buccal, mandibular and 
cervical. 
 
 In 70% of cases, anastomotic connections between the two main 
divisions exist. Anastomotic between the terminal branches of three 
temperofacial divisions are frequent, anastomosis between the two 
branches of the cervicofacial is likely to result in permanent paralysis 
than injury to the cervicofacial division. 
 
SURFACE ANATOMY     
The parotid gland’s anterior border is represented by a line passing 
downwards and forwards from the upper border of the mandibular 
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condyle to a joint just above the middle of the massester and then 
downwards and backwards to a point about 2 cm below and behind the 
angle to the mandible. Its upper border, concave upwards and backwards 
corresponds to a curved line drawn from the upper border of the 
mandibular condyle across the lobule straight line joining the ends of the 
anterior and upper borders. 
 
The parotid duct corresponding to-the middle third of the line 
drawn from the lower border of the tragus to a point midway between the 
ala of the nose and the red margin of the upper lip. 
 
BLOOD SUPPLY 
 Parotid gland has a rich vascularity being supplied by the branches 
from the external carotid artery through tributaries from the external 
facial, occipital, posterior auricular, internal maxillary and superficial 
temporal artery. The venous drainage is to the retromandibular or 
posterior facial vein. The position of the posterior facial vein is important 
clinically in that it is lateral to the superficial temporal artery and medial 
to the nerve and inferiorly it is a reliable land mark for the branches of the 
facial nerve. 
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LYMPH DRAINAGE 
 Lymph drains to the intra and extra glandular nodes and then along 
the external carotid artery to the jugulodigatric and other glands of the 
anterior superior group of upper deep cervical nodes. 
 
COMPARTMENTS OF THE GLANDS 
 The parotid may be considered to have 3 compartments. The 
superficial nerve compartment contains greater auricular nerve, 
auriculotemporal nerve and facial nerve. The middle venous compartment 
contains the superficial temporal vein joining the internal maxillary vein 
to form the posterior facial vein which joins the post auricular vein to 
form the external jugular vein. The deep arterial compartment contains 
the external carotid artery, internal maxillary artery and superficial 
temporal artery. 
 
STRUCTURE OF THE GLAND 
 It is composed of racemose glands, consisting only of serous 
alveoli which secrete a thin and watery fluid. Myoephithelial cells are 
seen around the periphery of the acini and intercalated duct. These act as 
contractile cells and apparently actively force secretions from the acini 
and intercalated ducts. 
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PHYSIOLOGY OF THE PAROTID GLAND 
  The total quantity of saliva produced during a 24hours period is 
about 1000-1500ml. About 90% of this fluid is derived from the parotid 
and submandibular glands in more or less equal amounts. 
 
 Parotid gland secretion is controlled by physical and psychic 
stimulation via the parasympathetic system. Afferent impulses are relayed 
to the superior and inferior salivatory nucleus with the tympanic branch 
of the 9th cranial nerve to the tympanic plexus (Jacobson’s nerve). From 
here the lesser superficial petrosal nerve carries impulses to the otic 
ganglion. Post ganglion fibres reach the parotid via the auriculotemporal 
nerve. Sympathetic fibres leave the ventral roots of the upper three 
thoracic ganglions. Post ganglionic fibres reach the parotid via the carotid 
plexus, traveling with the arterial supply to the gland.   
 
PAROTID NEOPLASMS 
Incidence 
 The incidence of salivary gland tumours in the U.S.A is 1.5 to 2 
per    1, 00,000 population of which 80-80%occur in the parotid glands. 
The incidence of malignancy in period tumours varies from 10-15% to 
20-30% in different series. 
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AETIOLOGY 
 There is no evidence either clinical or experimental to suggest that 
in the salivary glands a pre-existing inflammatory, obstructive or 
traumatic condition predisposes to malignant change. In experimental 
animals parotid tumours can be induced by carcinogenic hydrocarbons, 
ionizing radiations and viruses. Vitamin D deficiency may be important. 
 
PATHOGENESIS 
 An origin of salivary gland tumours from epithelial cells appears to 
be the current majority view. Some workers have postulated that the cell 
of origin may be individual cell types like the myoephithelial cells. 
Various tumours may arise from either intercalated or excretory ducts and 
this theory is based upon salivary gland embryogenesis and the potential 
duct epithelium during reactive process. 
 
 Electron microscopic studies have suggested that myoephithelial 
cell plays an important role in the growth and development of 
pleomorphic adenoma, adenoid cystic carcinoma, adeno lymphoma and 
oncocytoma. 
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CLASSIFICATION 
 The difficulty of histopathological interpretation, the presence of a 
wide range of histopathological patterns and the variable biological 
behaviour of salivary gland tumours led to a profusion of classification 
none of which have been universally accepted until the international 
classification of salivary tumours was formulated in 1972.  
 Some of the important classifications are: 
I. CLASSIFICATION BY F.W.FOOTE AND E.L.FRAZELL 
1. Mixed tumour 
a) Benign mixed tumour 
b) Malignant mixed tumour 
2. Mucoepidermoid tumours 
a) Low grade tumours 
b) High grade tumours 
3. Squamous cells carcinoma 
4. adeno carcinoma 
a) Adenoid cystic 
b) Miscellaneous-Trabecular of solid, or anaplastic mucous 
cells  
c) Acinic cells 
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5. Papillary cystadenoma lymphomatosum 
a) Oxphil adenoma  
b) Sebaceous cell adenoma 
c) Benign lymphoepithelial lesions 
d) Unclassified tumours-Benign and malignant   
II. CLASSIFICATION BY DAVID H.PATEY (1969) 
A.PRIMARY 
1. Epithelial 
 
a) Mixed tumours 
b) Mucoepidermoid tumour 
c) Cylindroma (adenoid cystic)  
d) Carcinoma – squamous cell carcinoma 
- Adeno carcinoma 
- Undifferentiated carcinoma 
e) Aden lymphoma (papillary cystadenoma lymphomatosum) 
f) Oxphil cell carcinoma  
 
2. Connective tissue 
a) Haemangioma 
b) Nueroma 
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B.SECONDARY 
 From various sources such as breast, bronchus, malignant 
melanoma etc., 
III. W.H.O. CLASSIFICATION OF SALIVARY GLAND 
TUMOURS (THACKRAY AND SOBIN 1972) 
1. EPITHELIAL TUMOURS 
 A. Adenomas 
1. Pleomorphic adenoma (mixed tumour) 
2. Monomorphic adenoma.  
 a) Aden lymphoma 
 b) Oxphilic adenoma 
 c) Others 
 B. Mucoepidermoid tumours 
 C. Acinic cell tumours 
 D. Carcinoma 
  1. Adenoid cystic carcinoma 
  2. Adeno carcinoma 
  3. Undifferentiated carcinoma 
  4. Epidermoid carcinoma 
  5. Carcinoma in pleomorphic adenoma 
 (Malignant mixed tumour) 
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II. NON EPITHELIAL TUMOURS. 
III. UNCLASSIFIED TUMOURS. 
IV. ALLIED CONDITIONS. 
a. Benign lympho-epithelial lesions 
b. Sialosis 
c. Oncocytosis 
 
PLEOMORPHIC ADENOMA (Mixed tumour) 
 It is most common tumour of the salivary gland. It is of epithelial 
origin and benign. The term pleomorphic was coined by Willis in 1967. it 
forms 60-70% of all parotid tumours and 80% of all benign tumours. It is 
usually unilateral. It is purely of epithelial origin. Material in 
chondromyxoid areas has been considered to be a modified type of 
mucin, made up of chondroitin, a mucopolysaccaride elaborated by the 
myoephithelial cells. The maximum incidence is seen in the 5th decade 
and sex distribution is equal. 
 
Gross pathology 
 It forms an irregular lobulated, roughly globular mass having a 
capsule. The cut section is firm and white bluish area of cartilage like 
appearance. The consistency depends on the amount of mutinous material 
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and varies from firm to soft. The tumour expands by focal growth 
producing nodular extensions into the capsule. Operative enucleation of 
the tumour is frequently responsible for leaving satellite nodules this 
accounts for frequency and multiplicity of recurrent nodules after such 
operations.   
 
Microscopic pathology 
 A mixed tumour consists of epithelial and mesenchyme like 
elements. In the epithelial component, the cells may be arranged in sheets 
or lie sparsely in a mucoid of chondromyxomatous matrix. In the mucoid 
and myxoid areas, myoephithelial cells are present. The cartilaginous 
areas may calcify or ossify. 10% tumours are highly cellular and such 
tumours are liable to recur. The tumour is relatively radio resistant and 
careful local excision with a margin of normal tissue is the treatment of 
choice. 
 
 Foote and Frazell (1954) reported 86 recurrences in 494 patients 
(17.3%). Superficial parotidectomy will result in a recurrence rate of less 
than 5%. Post operative irradiations of 6000 to 6500 rads have been 
added in selected cases in which a subsequent recurrence would be 
almost impossible to manage surgically. Pleomorphic adenomas after 
10,20 or 30 years can turn malignant.  
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2. MONOMORPHIC ADENOMAS  
 These benign tumours are characterized by the regularity of their 
cell structure and pattern 
a) ADENOLYMPHOMA (Warthin’s tumour)    
 This is the second most benign tumour of the parotid gland. The 
Aden lymphoma is a distinctive tumour which arises almost constantly in 
relation to the parotid gland in a superficial location, especially at the 
lower pole. This benign tumour is believed to arise from heterotypic 
gland tissue which has become enclosed developmentally in a lymph 
node. It is the only functional tumour arising from parotid gland. 
 The lesion appears as a slow growing soft tissue mass in males 
over the age of 40 years. Commonly the lesion arises multifocally and a 
striking clinical feature is that bilateral gland involvement occurs in 7 to 
10% of cases.  
 
Gross Pathology  
 Aden lymphoma seen as a rounded or slightly lobulated mass 
completely encapsulated. It is soft and cystic. The cyst may contain 
papillae and also musky mutinous substances. 
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Microscopic Pathology  
 Histologically, the tumour is composed of glandular and often 
cystic structures having a papillary cystic pattern lined by columnar cells. 
A variable amount of lymphoid tissue with follicle formation 
characterizes the stroma. 
 
 Aden lymphoma concentrates 99 TC predestinate at much greater 
degree than normal salivary tissue.  
 
b) Oxphil Adenoma (Oncocytoma) 
 This tumour is very uncommon in the parotid. They are round or 
ovoid, encapsulated, solid tumours of slow growth which usually occurs 
in a higher age group. The tumour cells resemble oncocytes which are 
cell derives from the duct epithelium. This tumour has a predilection for 
older females.  
 
c) Basal Cell Adenoma 
 This is a rare type of monomorphic adenoma. It is usually found in 
the superficial part of the gland. It is also slow growing, encapsulated 
solid tumour seen in older individuals. The histologic picture is very 
similar to that seen in basal cell carcinoma arising from stratified 
epithelium.   
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d) Clear Cell Adenoma 
 This is also a rare monomorphic adenoma. In this tumour, duct like 
structures surrounded by clear cells in the position normally occupied by 
myoephithelial cells is seen. 
 
 
B. MUCOEPIDERMOID TUMOUR 
 Mucoepidermoid tumours form 2-5% of all salivary tumours out of 
which 70-90% occur in the parotid tumours and 25% of malignant parotid 
tumours. It is commonly seen in the 3rd to 5th decade with an equal withy 
an equal sex incidence. It is the commonest salivary gland tumour in 
childhood. It is slow growing and not encapsulated. 
 
Gross Pathology 
 These tumours are ovoid and well circumscribed. Infiltration may 
be evident with ulceration of the overlying surface. These tumour always 
show an attachment to fascia. The cut surface shows solid elements and 
cyst filled with a viscid mucin. 
 
Microscopic Pathology 
 It is characterized by the presence of squamous cells, mucus 
secreting cells and cells considered to be of an intermediate type. 
Depending on the proportion of each, the tumour may be solid or cystic. 
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 Mucoepidermoid tumours infiltrate locally and though they may 
metastasise, this ability is limited. 
 
C. ACINIC CELL TUMOUR 
  This tumour constitutes about 1% of all salivary gland tumours and 
accounts for 2-4% of all parotid tumours. Similar to warthin’s tumour, it 
may be bilateral. The peak incidence is in the 5th decade. These are 
solitary lesions, compact, hard and knobby and mobile. 
 
Gross Pathology 
 This tumour is apparently encapsulated, hard and presents a most 
grey white cut surface flecked with brown areas. Small cyst containing 
serous and blood stained fluid may also be found. 
 
Microscopic Pathology 
 Uniformly round polygonal cells with abundant basophilic and 
granular cytoplasm are commonly arranged in solid sheets or mosaic 
fashion. Large non granular and clear cells may be present. Marked PAS 
reaction of granules within the neoplastic cells may be present. Marked 
PAS reaction of granules within the neoplastic cells is a useful 
histochemical reaction in the diagnosis of acinic cell tumour. 
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 A 5 year survival rate of around 90% makes it a much more benign 
tumour than Mucoepidermoid tumour. Rarely the tumour may infiltrate 
locally or metastasis. 
 
D. CARCINOMAS 
 Malignant diseases of the salivary glands are rare. Half of them 
occur in the parotid. About 25% of parotid tumour are malignant. 
 
 The natural course of many of these neoplasms was characterised 
by long duration, repeated local recurrences, occasional metastasis to the 
regional lymph nodes and lungs. All these neoplasms tend to present at an 
early stage to produce obvious clinical signs of malignancy. 
 
1. Adenoid Cystic Carcinoma 
 This tumour is relatively rare in the parotid gland. It forms 2% of 
parotid tumours. The peak incidence is in the 6th decade (18%). The 
incidence of lymph node metastasis from direct or contiguous invasion 
rather than emboli is low (15%). 
 
Gross Pathology 
 Adenoid cystic carcinoma usually presents as a firm tumour 
composed of pink grey tissue with a moist cut surface. It infiltrates slowly 
and so its margins are ill defined. 
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MICROSCOPIC PATHOLOGY  
 This tumour is composed of basal type epithelial cells and of a 
stroma which is variably hyaline. The epithelial cells may be arranged in 
solid, granular, cribriform or cystic masses. The adenoid cystic carcinoma 
is isomorphic lacking the marked and varied stromal changes so 
characteristic of pleomorphic adenoma. Adenoid cystic carcinoma 
metastasizes distantly especially to the lungs. 
 
2. ADENOCARCINOMA 
 Aden carcinoma form 3% of parotid tumours. There is 23% of 
incidence of preoperative facial paralysis. They are all highly malignant 
tumours that metastasis widely. Their prognosis is determined by the 
grade and stage of the tumours rather than by the extent of surgery. Local 
recurrence of this most lethal tumour exceeds 50%. 
 
3. SQUAMOUS CELL CARCINOMA 
 This is a rare tumour of parotid glands affecting the males 
predominantly. This tumour grows rapidly and about one half of the 
patients have metastatic lymph nodes when first seen.   
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Gross Pathology 
 This tumour consists of epithelial cells which form keratin or 
exhibit intercellular bridges. It arises from the ductal system and the 
prognosis is grave. 
 
4. UNDIFFERENTIATED CARCINOMA 
 These are poorly differentiated malignant tumours of epithelial 
origin. These include the solid undifferentiated carcinoma, Trabecular 
carcinoma and salivary duct carcinoma. The presence of epithelial and 
myoephithelial cells in these tumours have been shown by electron 
microscopy.  
 
5. CARCINOMA IN PLEOMORPHIC ADENOMA 
 This tumour is one in which there is areas of invasive growth and 
cellular atypia together with histological areas of typical pleomorphic 
adenoma. 
 
 Malignant change in a previous simple tumour of long standing 
duration occurs in 2 to 4% cases. There is an accelerated recurrence rate 
and a high incidence of metastasis (30-70%). 
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II NON EPITHELIAL TUMOURS 
 Non epithelial stromal tumours of the parotid are rare. They 
include haemangioma, lymphangioma, nuerofibroma, lipoma, sarcoma, 
metastatic tumours and lymphoma. Junaid et. al., has reported a rare 
incidence of dermatofibrosarcoma protruberans of the parotid gland. 
 
CLINICAL FEATURES: 
 Tumours of the parotid gland often present with painless or 
asymptomatic swelling. Usually the mass is situated behind the angle of 
the jaw or overlying the ramus of the mandible, below and in front of the 
ear, often lifting the tragus and the ear lobe. 
 About 10% of the tumours arise in the deep lobe, some of which 
may present as palatal swelling or rarely as a dumb bell tumour. 
Accessory parotid is the site of tumours in 1% of cases. Occasionally 
parotid tumours may present with pain. Sometimes dull pain may be the 
only early symptom of a carcinoma of the deep lobe. Malignant tumours 
commonly present with rapidity of growth and signs of infiltration such 
as fixation, pain, paralysis of facial muscles, anesthesia of skin or mucous 
membrane, resorption of adjacent bone, temporomandibular joint 
involvement and ulceration of skin. The commonest presenting feature of 
adenoid cystic carcinoma is pain. 
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 Normal histology     Pleomorpic adenoma                            
                  
 Warthin s Tumour        Oncocytoma 
                 
 Basal cell adenoma    Mucoepidermoid  
              
     Adenoid cystic carcinoma          Adenoid cystic carcinoma 
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        Adeno carcinoma 
   Malignant pleomorpic 
    Squamous cell carcinoma 
     Undifferentiated carcinoma 
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STAGING OF PAROTID GLAND CANCERS 
 The American joint committee staging of salivary gland tumours is 
as follows: 
 
PRIMARY TUMOUR 
Tx - Primary tumour cannot be assessed 
T0 - No evidence of primary  tumour. 
T1 - Tumour less than 2 cms in greatest dimension without 
extraparenchymal extension 
T2 - Tumour >2 CM<4cm in greatest dimension without 
extraparenchymal extension 
T3 - Tumour more than 4 cm and / or tumour having 
extraparenchymal extension 
T4a - Tumour invades skin, mandible, ear canal,and/or facial nerve 
T4b - Tumour invades skull base and / or pterygoid plates and/or 
encases carotid artery.  
 
NODAL INVOLVEMENT 
 Nx - Regional lymph nodes cannot be assessed 
 N0 - No regional lymph node metastasis 
          N1 - Metastasis in single ipsilateral lymph node, 3 cm or less in 
                   greatest dimension 
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           N2a - Metastasis in single ipsilateral LN, > 3 cm but < 6 cm  
           N2b- Metastasis in multiple ipsilateral LN, none> 6 cm 
           N2c- Metastasis in bilateral or contralateral LN, none > 6 cm 
           N3 – Metastasis in a lymph node, more than 6 cm  
 
METASTASIS 
           MX - Distant metastasis cannot be assessed 
 M0 - No distant metastasis 
 M1 - Distant metastasis to lungs, bone etc.,  
STAGE GROUPING T N M 
STAGE I T1 N0 M0 
STAGE II T2 N0 M0 
STAGE III T3 N1 M0 
 T1 N1 M0 
 T2 N1 M0 
 T3 NO M0 
STAGE IVA T4a N1 M0 
 T4a N2 M0 
 T1 N2 M0 
 T2 N2 M0 
 T3 N2 M0 
 T4a N2 M0 
STAGE IVB Tb Any N M0 
 Any T N3 M0 
STAGE IVC Any T Any N M1 
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INVESTIGATIONS 
 A number of diagnostic tests are available. They are, 
1. Sialography 
 It is done by injecting 1-2cc of a various contrast medium 
(Lipoidol), over distension is avoided by stopping the injection when the 
patient complains of pain. Sialography fails to detect parotid neoplasms 
less than 1cm in diameter. It can however give an idea of deep lobe 
involvement. Benign lesions displace the ductal system whereas 
malignant lesions may infiltrate it causing ductal obstruction. 
 
2. Radiosialography 
 For Radiosialography 1 Mci of 99 TcM labeled sodium 
pertechtinate is injected intravenously and the parotids are scanned using 
a gamma camera. All parotid neoplasms other than Warthin’s tumour and 
oncocytoma are radionegative. 
 
3. Ultrasonography 
 Both benign and malignant lesions appear as solid masses except 
Warthin’s tumour which is sonoluscent at low gain settings while 
showing internal echoes at high setting. 
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4. Computed Tomography (CT) and MRI 
 CT and MRI is currently the radiographic study favoured in the 
investigations of parotid neoplasms. CT with IV contrast is useful in 
separating intrinsic parotid masses from paraparotid masses as well as 
differentiating deep lobe masses from other parapharyngeal space masses. 
In addition during the same scan axial sections of the neck may be taken 
to investigative metastatic adenopathy. It is also useful in detecting 
distant metastasis. 
 
5. Angiography 
 This is useful in tumours of the parapharyngeal in order to 
differentiate salivary gland tumour from chemodectoma of the cartotid 
sheath or a neoplasm of the nerve shealth, both of which have a 
characteristic tumour circulation. 
 
6. Fine Needle Aspiration Biopsy (FNAC) 
 This is an important investigation in the diagnosis of a parotid 
mass. Using this technique Eneroth et an were able to provide tumour 
diagnosis in 92% of 1000 cases with histologically verified tumours. 
Frable and frable (1974) reported a diagnostic accuracy of 80% for 
adenoid cystic carcinoma, 62% for Mucoepidermoid carcinoma, 65% for 
acinic cell carcinoma 100% in a pleomorphic adenoma. This test is 
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especially accurate in pleomorphic adenoma. This information obtained 
from this test can be extremely valuable in planning the operative 
procedure and in information the patient of the relative likelihood of 
having to sacrifice all or part of the facial nerve. 
 
7. Incisional Biopsy 
 Incisional biopsy of the parotid is not without risk. Damage to 
important neurovascular structures, the creation of salivary fistulas and 
the contamination of tissue planes by neoplastic cells are the serious risks 
involved, furthermore, fibrosis at the site of biopsy can make later 
surgery difficult. On no account should a discrete parotid mass be 
subjected to Incisional biopsy since there is a 9 cut off 10 chances that the 
mass is a pleomorphic adenoma, incising which will almost certainly lead 
to a late recurrence. 
 
8. Frozen section biopsy 
 The use of frozen sections made during operation overcomes some 
of the disadvantages outlined above. However the histopathology of 
salivary gland neoplasm is a complex field and interpretation especially 
of frozen section can be difficult. 
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9. Needle biopsy 
 Needle biopsy using tru-cut or vim silvermann needle can be done 
under local analgesia, but carries all he risks of Incisional biopsy through 
of lesser degree. Some authors claim very little spillage along the needle 
tract. 
 
DIFFERENTIAL DIAGNOSIS OF PAROTID TUMOURS 
 Some of the rarities that mimic parotid swellings are: 
 Hypertrophic masseter 
 Winged mandible (in the 1st arch syndrome ) 
 Dental cysts 
 Branchial cysts 
 Myxoma of the masseter 
 Mandibular tumours 
 Lymphadenitis of the preauricular lymph node 
 Secondaries of neck.  
 
TREATMENT  
TREATMENT OF BENIGN TUMOURS 
 The treatments of benign tumours have passed through several 
phases during the last 30 years. Enucleation carried a high recurrence rate 
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and so it was followed by enucleation and post operative irradiation. But 
this carried on with it risk of radiation induced cancer in the young. So 
removal of the growth with a good cuff of normal parotid tissue was 
practiced later. However this resulted in a facial weakness in some cases. 
A superficial conservative parotidectomy became the accepted surgery 
for benign lesions confined to the superficial lobe. For lesions in the deep 
lobe, a total parotidectomy with conservation of the facial nerve is 
advisable. In all cases, the patent must be informed preoperatively of the 
possibility of injury to the nerve and should give his knowledge consent 
for the treatment. 
 
TREATMEN OF MALIGNANT LESIONS 
TREATMENT 
GROUP 
TUMOUR TYPE TREATMENT 
I T1&T2 low grade 
Mucoepidermoid& acinic 
cell tumour 
Superficial / total 
conservative parotid 
dectomy 
II T1&T2 low grade 
Mucoepidermoid& all 
other tumours 
Total parotidectomy 
(conservative)+ Node 
dissection for N1 
III T3N0 or N1 
IV T4 
Radial parotidectomy+ 
node dissection for node 
positive cases+ post 
operative radio- therapy + 
facial nerve reconstruction 
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SURGERY 
PAROTIDECTOMY 
 Parotidectomy may be conservative when all the main branches of 
the facial nerve are preserved or radical when the entire trunk and portion 
of the facial nerve is sacrificed. Depending upon the part removed, it may 
be superficial, deep or total. Deep parotidectomy is not recommended 
because of risk of fistula formation, moreover, it is difficult to approach 
the deep lobe with the superficial lobe in situ .Incision used : lazy S. 
 
 The basic operation for parotid neoplasm is the superficial 
parotidectomy. This procedure will suffice for all superficial lobe benign 
neoplasms. The structure of paramount importance in a parotidectomy is 
the facial nerve. The only constant location of the nerve has to be traced 
from this point. There are other approaches which involve identifying a 
peripheral branch and following it retrograde to the main trunk. Facial 
nerve function should be checked immediately prior to skin closure, 
should be performed. Because of the overlying nerve fibres, any effort to 
remove all of the deep lobe will necessarily be in piecemeal only. 
 
 In adenoid cystic carcinoma, the nerve excision should be wide be 
cause the tumour infiltrate nerve sheaths and eventually travel 
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intracranically. The facial nerve should be removed well into the mastoid 
drilling it out of its bony canal. 
 
NECK DISSECTION 
 Radial neck dissection should be carried out in the presence of 
involved nodes and this should be done prophylactically for squamous 
cell carcinoma and undifferentiated carcinoma. Goonde at all (1960) 
found it helpful to remove a ‘sentinel node’ located at the junction of the 
anterior and posterior facial vein for frozen early in the operation. If the 
node is involved by the tumour enblock neck dissection is performed. 
However the study conducted in the University of Virginia recommends 
neck dissection only for palpable lymph node Secondaries. 
 
COMPLICATIONS OF PARATIDECTOMY 
1. Reactionary Haemorrhage 
2. Facial nerve paresis / paralysis 
a. Transient 
b. Permanent  
3. Frey’s syndrome 
4.  Salivary fistula 
5. Flap necrosis 
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6. Infection 
7. Keloid 
8. Cosmetic disfigurement 
9. Paraesthesia of ear lobule 
10. Seeding and spillage of tumour cells and consequent recurrence. 
 
RADIO THERAPY 
 Unfortunately most salivary neoplasms are relatively radioresistant. 
However radiotherapy has been useful in reducing locoregional 
recurrence significantly in patients with stage II and stage III disease. A 
dose of 5000-6000 rads is given to the parotid bed. It is given within 6 
weeks after surgery. Most adenoid cystic carcinoma requires post 
operative radiotherapy irrespective of their site of origin. 
The general indications for radiotherapy are:  
1. Residual malignant tumour after surgery. 
2. Microscopic malignant tumour at resected margin. 
3. Unresectable primary carcinoma 
4. Unresectable recurrent malignant tumour 
5. Malignant lymphoma 
6. Metastatic salivary gland carcinoma 
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Major complications of irradiation include soft tissue ulceration, 
orocutaneous fistulas and osteoradionecrosis of the mandible. 
 
CHEMOTHERAPY 
 Recently objective responses with cis-platin or Adriamycin based 
chemotherapy in some patients with inoperable or metastatic parotid 
cancer have been observed. Schramm et al., (1981) has shown good 
response for adenoid cystic carcinoma to cis-platin 80-100mg/m2 at 4-6 
weeks intervals with subjective relief of pain and regression of the 
primary lesion. Responses might be prolonged with addition of 
radiotherapy. 
 
PROGNOSIS 
 Prognosis of benign tumours is excellent with no recurrence 
provided the treatment is by adequate resection. The prognosis of low 
grade Mucoepidermoid and acinic cell tumours is good. Adenoid cystic 
carcinoma has a five years survival rate of 60-80%. The malignant 
pleomorphic adenoma has the worst prognosis among all parotid gland 
neoplasms. 
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AIM OF STUDY 
 
1. To review the literature of parotid gland tumours in the light of 
their histologic classification. 
2. To analyse the various modes of clinical presentation and their 
correlation with histopathology. 
3. To compare the incidence, clinicopathological presentation and 
method of treatment of this study with various other reports in the 
literature. 
4. To infer whether a more radical procedure is associated with a 
greater risk to the facial nerve. 
5. To study whether recurrence after a conservative procedure is 
controllable by further surgery without undue risk to the patient. 
6. To study the effectiveness of radiotherapy in the post operative 
management of malignant parotid tumours. 
7. To study the effect of chemotherapy in the management of 
inoperable malignant tumours. 
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MATERIALS AND METHODS 
 
 54 cases of parotid tumours treated in Govt.Rajaji Hospital, 
Madurai during the period of 24 months (Oct 2006 to Oct 2008) have 
been taken for the present study. It has been taken and recorded according 
to the proforma given below. 
 
 The diagnosis of parotid tumour was made with the aid of clinical 
findings. A special investigation like fine needle aspiration cytology was 
done in most cases. 43 out 54 cases were subjected to surgical treatment. 
The confirmation of diagnosis and identification of specific type of 
tumour was done by histopathological examination of the excised 
specimen. Radiotherapy was given for appropriate cases following 
surgery. 
 
 Follow up of the patients have been done by asking them to report 
for check up. Effective follow up has been possible for only about 3-6 
months following treatment, many being lost to follow up after that. 
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PAROTID GLAND NEOPLASMS 
A CLINICOPATHOLOGICAL ANALYSIS 
PROFORMA 
SI. NO   OP/IP NO.    WARD NO. 
 
NAME     AGE    SEX: 
ADDRESS     RELIGION 
 
OCCUPATION    INCOME     
Date of Admission : 
Date of Operation : 
 Date of Discharge : 
Complaints and history of present illness: 
1. Swelling in the parotid region 
a. Duration 
b. Unilateral / Bilateral 
c. Mode of onset- Acute / insidious 
d. Progress of symptoms 
2. Pain-Present  / Absent 
If present any relation with food intake or seeing food. 
3. Fever-Present / Absent 
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4. Discharge from stenson’s duct – Present / Absent 
If present-nature of discharge- Purulent/Watery-Quantity 
little/profuse  
5. Any other swellings  
6. Loss of appetite 
7. Loss of weight 
8. Abdominal pain 
9. Others 
PAST HISTORY 
1. Mumps    2. Trauma to parotid area 
3. Diabetes mellitus  4. Hypertension 
5. Jaundice    6. Similar illness 
7. Treatment-if any  8. Operations- if any 
FAMILY HISTORY    
1. Members in family with similar illness 
PERSONAL HISTORY 
 Diet    Addictions  -smoking, alcohol, tobacco chewing 
LOCAL EXAMINATION 
Inspection 
1. Unilateral / bilateral 
2. Site 
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3. Size 
4. Shape 
5. Diffuse / Localised 
6. Surface-Smooth / irregular 
7. Skin over the swelling 
8. Visible pulsations-present / absent 
9. Ear lobe lifted or not 
10. Oral cavity, Stenson’s duct orifice 
11. Tonsils and oropharynx 
12. Stenson’s duct orifice 
13. Mandibulo mastoid groove obliterated or not 
Palpation 
1. Temperature over the swelling- Normal/raised 
2. Tenderness-Present/absent 
3. Consistency-Soft/firm/hard/variable 
4. Mobility-Absent/present/restricted 
5. Fixity to the surrounding structures-Present/absent 
6. Plane of swelling / Bimanual palpation 
7. Pulsation-present/absent 
8. Thrill-present/absent 
9. Transluminency-present/absent 
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Auscultation    Bruit-present/absent 
  
B.STENSON’S DUCT: 
 a. discharge-present/absent 
  If present-nature-purulent/watery-quantity 
b. Stones-present/absent 
c. Strictures-if any 
d. Thickening of the duct-if any 
C. Fistula if any 
D. Movement of the jaw 
E. Involvement of facial nerve 
F. Enlargement of lymphnodes 
G. Other relevant of lymphnodes 
 H. Examination of   Oral cavity 
                                 Oro pharynx 
 
Systematic examination 
1. CNS 
2. CVS 
3. R.S. 
4. GIT 
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TREATMENT 
A) Surgery 
a. Type 
b. Findings 
c. Post operative period 
d. Post operative complications if any 
 
1. Wound infection 
2. Fistula 
3. Injury to facial nerve 
4. Recurrence 
5. Any other complications 
B) Radio therapy 
C) Chemotherapy 
Post surgical histopathology report 
Follow-Up: 
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OBSERVATIONS 
TABLE I 
INCIDENCE OF PAROTID TUMOURS DURING THE PERIOD 
Type of patients Total number of 
admissions 
Total number of 
parotid tumours 
% of parotid 
tumours 
All cases 72113 54 0.0748 
 
TABLE II 
INCIDENCE OF EPITHELIAL AND NON-EPITHELIAL 
TUMOURS OF PAROTID GLAND IN THE STUDY 
S.NO Type of tumour Number of cases Percentage 
1 Epithelial  54 100.0 
2 Non epithelial  0 0 
 Total 54 100.0 
 
TABLE III 
INCIDENCE OF BENIGN AND MALIGNANT EPITHELIAL 
TUMOURS OF THE PAROTID GLAND IN THE STUDY 
S.NO Type of tumour Number of cases Percentage 
1 Benign 39 72.22 
2 Malignant 15 27.77 
 Total 54 100.0 
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INCIDENCE OF BENIGN AND MALIGNANT EPITHELIAL 
TUMOURS OF THE PAROTID GLAND IN THIS STUDY 
 
 
28%
72%
benign
malignant
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TABLE IV 
INCIDENCE OF VARIOUS HISTOLOGICAL TYPES OF 
EPITHELIAL TUMOURS OF THE PAROTID GLAND IN THE 
STUDY 
S.No Type of tumours No. of 
cases 
of total
Percentage Male  Female 
1 Benign 39 72.22    28       11 
 a)Pleomorphic 
adenoma 
37 94.87 26 11 
 b)Adenolymphoma 2 5.12 2 0 
2 Malignant 15 27.77 11 4 
 a)Mucoepidermoid 
tumour 
7 46.67 5 2 
 b) Adenocarcinoma 3 20.00 3 0 
 c) Anaplastic 
carcinoma 
1 6.66 1 0 
 d) Adenoid cystic 
carcinoma 
2 13.33 1 1 
 e) Malignant 
pleomorphic 
2 13.33 
 
1 1 
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histological types of parotid gland 
tumours
pleomorpic
adenoma
adenolymphoma
mucoepidermoid
adenocarcinoma
anaplastic ca
adenoid cystic ca
malignant pl.ad
 
 
 
 
 
 
 
 
 
Pleomorpic adenoma 66.66% 
Adenolymphoma 3.7% 
Mucoepidermoid 11.11% 
Adenocarcinoma 5.55% 
Anaplastic ca 1.85% 
Adenoid cystic ca 3.7% 
Malignant pl. adenoma 3.7% 
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TABLE V 
PRESENTING SYMPTOMS AND SIGNS OF 52 PATIENTS WITH 
PAROTID GLAND TUMOUR IN THE STUDY 
S.No. Presenting symptoms No of cases  % 
1 Mass only 33 63.46 
2 Mass with pain 15 28.84 
3 Mass with facial palsy 5 9.62 
4 Mass with ulceration or 
skin fixity 
5 9.62 
5 Mass with recent rapid 
increase in size 
4 7.69 
6 Mass with 
temporomandibular joint 
involvement 
3 5.77 
7 Mass with upper deep 
cervical nodes 
4 7.69 
  
 A mass in the parotid region was the most consistent presenting 
complaint and was present in all 54 cases. Left parotid gland was the seat 
of tumour in 36 cases and right in 18 cases. No bilateral tumours were 
seen. The mass was smooth surfaced in 6 cases and nodular in 48 cases. 
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Among the malignant tumours the pre-operative diagnosis was correct in 
10 cases. 2 cases that presented only with a mass were diagnosed as 
pleomorphic adenoma and FNAC was inconclusive. The histological 
type-Mucoepidermoid carcinoma was proved by the histopathological 
report of the surgical specimen. 
 
Pleomorphic adenoma 
 There were 37 cases of pleomorphic adenoma in this series forming 
33 % of all epithial tumours and 94.73 of all benign tumours. There were 
28 males and 11 females with a male female ratio of 2:1. The youngest 
patient was a 16 year old male patient and the oldest was a 66 year old 
male patient. Maximum incidence was seen between 30-40 years. 
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TABLE VI 
AGE AND SEX DISTRIBUTION OF 36 CASES OF 
PLEOMORPHIC ADENOMA 
Age group Total no. of 
cases 
Males Females  
11-20 1 1 0 
21-30 4 1 3 
31-40 13 11 5 
41-50 11 9 2 
51-60 4 3 1 
61-70 3 3 0 
Total 36 28 11 
 
TABLE VII 
PRESENTING SYMPTOMS AND SIGNS OF 37 PATIENTS WITH 
PLEOMORPHIC ADENOMA IN THE STUDY 
S.NO Presenting symptom 
and signs 
No. of cases Percentage  
1 Mass only 30 81.08 
2 Mass with pain 6 16.21 
3 Mass with ulceration - - 
4 Recurrent mass  1 2.70 
5 Mass with facial palsy - - 
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            An asymptomatic parotid lump was the most common presenting 
feature. Most of the lesions were present for 1 to 4 years prior to 
diagnosis. One patient had involvement of both lobes while in all the rest, 
only the superficial lobe was involved. The diagnosis was based mainly 
on clinical examination. FNAC was done in all cases. It offered positive 
rate 91.89% (34 out of 37 cases). 
TABLE VIII 
SURGICAL TREATMENT OF 32 CASES OF PLEOMORPHIC 
ADENOMA 
S.No. Surgery Number of cases Percentage  
1 Superficial parotidectomy  29 78.37 
2 Total parotidectomy 
(conservative) 
3 8.19 
3 No surgical treatment 5 13.51 
 
             5 patients were not offered any surgical treatment. One patient 
was severely anaemic (Hb 3.8 gm %) and a hypertensive. Another patient 
was a female patient who was engaged – to be married the next month. 
So when the risk of injury to the facial nerve was explained to her, she 
refused surgery. The other three patients left the hospital when surgery 
advised to them. 
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TABLE IX 
POST OPERATIVE COMPLICATIONS SEEN IN THE 32 
OPERATED CASES 
S.No Complication Number of cases Percentage 
1 Facial nerve palsy 6 18.75 
 a) Transient 4 12.5 
 b) Persisting 2 6.25 
2 Haematoma 2 6.25 
3 Seroma - - 
4 Wound infection 2 6.25 
5 Salivary fistula 1 3.13 
6 Flap necrosis 3 9.38 
7 Keloid - - 
8 Recurrence 1 3.13 
 
 Facial nerve palsy was seen in 6 patients. It recovered within 6 
weeks in 4 patients, 2 patients had persisting facial palsy 3 months follow 
up. Both the cases had undergone enucleation. The buccal branch was 
affected in both the cases and the zygomatic branch in one case. There 
was no incidence of Frey’s syndrome. One patient, when enucleation was 
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done, presented after 12 months with recurrence of the lesion. He refused 
any further intervention by way of surgery. 
Adenolymphoma (Warthin’s tumour)  
 In this series, there were two cases of Adenolymphoma. Both were 
male patients, one 58 years old and the other 62 years old. The duration 
of symptoms was 6 years and 3 years respectively. Mass was the only 
presenting symptom. It was soft in consistency and mobile. Both did not 
have facial palsy. FNAC was done in both cases. The report came as 
benign epithelial cells. The surgical treatment were as follows: 
 Superficial parotidectomy-1 
 Enucleation-1 
 The patient for whom enucleation was done developed post 
operative facial palsy. 
 
MALIGNANT TUMOURS 
 There were 15 patients with malignant tumour in this series. There 
were 11 males and 4 females patients. The size of the lesions varied from 
4 to 20 cms, 9 of them had pain at the time of presentation 5 of them had 
facial nerve involvement. 5 of them had ulceration or skin fixity.  3 of 
them had temporomandibular joint involvement and 4 had involvement of 
the upper deep cervical nodes. 
 
60
TABLE X 
THE INCIDENCE OF VARIOUS TYPES OF MALIGNANT 
TUMOURS OF THE PAROTID GLAND IN THE STUDY 
  
S.No Type of tumour  Number of cases Percentage 
1 Mucoepidermoid tumour 7 46.66 
2 Adeno carcinoma 3 20.00 
3 Adenoid cystic carcinoma 2 13.33 
4 Anaplastic carcinoma 1 6.66 
5 Carcinoma in 
pleomorphic adenoma 
2 13.33 
6 Acinic cell tumour - - 
 Total 15 100.00 
     
Mucoepidermoid tumour 
 There were 7 patients with tumour. All the patients were over 50 
years of age. 3 out of the 7 patients presented only with a mass and no 
other symptoms. None of the patients had facial palsy. 2 patients had skin 
ulceration. FNAC was done for all the patients. It was negative in the two 
patients, with mass only. It showed dysplastic cells in the remaining 45 
patients. For the two patients who presented with mass only it was  
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THE INCIDENCE OF VARIOUS TYPES OF MALIGNANT 
TUMOURS OF THE PAROTID GLAND IN THIS STUDY 
47%
20%
13%
7%
13%
0%
Mucoepidermoid tumour Adeno carcinoma
Adenoid cystic carcinoma Anaplastic carcinoma
Carcinoma in Pleomorphic adenoma Acinic cell tumour
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misdiagnosed as pleomorphic adenoma and a superficial parotidectomy 
was done. The post operative histological report came as 
mucoepidermoid carcinoma. These patients were given postoperative 
radio therapy. For 4 patients total conservative parotidectomy was done, 
post operative radio therapy was not given to the patients. There has been 
no recurrences in the short follow up. Two patients developed wound 
infection in the post operative period. 1 patient left the hospital when 
adviced surgery.    
 
Adeno carcinoma 
 The incidence of Adenocarcinoma in this series is 20%. One of 
these patients presented with facial nerve involvement and ipsilateral 
upper deep cervical nodes. The other patient had involvement of the 
facial nerve and infiltration of the growth into the tempereromandibular 
joint with associated truisms. For the first patient a radical parotidectomy 
with ipsilateral neck dissection was done. Post operatively the patient was 
subjected to radiotherapy. There was no recurrence during the short 
follow up. The latter patient was put on chemotherapy using cis-platin, 
cyclophosphamide and 5- fluorouracil. The patient showed no response to 
chemotherapy initially and was lost to follow up after 2 months.  
 
63
 
Anaplastic carcinoma 
 The incidence of anaplastic carcinoma in this series is 6.66%. A 50 
years old male patient presents with a mass, facial nerve involvement, 
upper cervical nodes, temporomandibular joint involvement and skin 
fixity. FNAC showed dysplastic epithelial cells. Neoadjuant CT, followed 
by debunking parotidectomy and post operative radiotherapy was given; 
 
Adenoid cystic carcinoma   
  The incidence of adenoid cystic carcinoma in this study was 
13.33% a 40 year old female patient presented with a recurrent 
ulceroproliferative growth in the right parotid region. The 
histopathological report was adenoid cystic carcinoma. She was put on 
chemotherapy cis-platin, cyclophosphamide and 5-flurouracil, initial 
response to chemotherapy was satisfactory with reduction of pain and in 
the size of lesion. The patient was lost to follow up. 
 
Malignant pleomorphic adenoma: 
 The incidence of malignant pleomorphic adenoma in this series is 
13.33%. Both the patients had tumour in the region of the parotid for long 
duration (8 and 11 years) and there is a history of sudden increase in size, 
in both cases. One had involvement of the facial nerve, upper deep 
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cervical nodes and the temporomandibular joint. This patient was put on 
chemotherapy with cis-platin. 
 
 The other patient had skin involvement and a mass. A radical 
parotidectomy with post operative radiotherapy was given to the patient. 
The histopathological report was pleomorphic adenoma turning 
malignant, squamous cell type. Tumour recurrence was not noted at 
follow up. (2 months) 
TABLE XI 
TREATMENT OFFERED TO MALIGNANT PAROTID 
TUMOUIRS IN THE STUDY 
 
S.No Treatment  Number of cases Percentage 
1 Superficial parotidectomy 
and post operative 
radiotherapy 
3 21.42 
2 Total parotidectomy 5 35.71 
3 Radical parotidectomy - - 
4 Radical parotidectomy with 
post operative radiotherapy 
2 14.29 
5 Radical parotidectomy with 
lymph node dissection + 
radiotherapy 
1 7.14 
6 Chemotherapy only  3 21.43 
 Total  14 100.0% 
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DISCUSSION 
 
 
 The present study is based on a small series and short follow up 
Hence it is a difficult task to compare the present study with those found 
in the literature and arrive at a meaningful conclusion. However a sincere 
effort is made to do so in the following pages. 
 
PLEOTROPHIC ADENOMA 
 This is the commonest benign tumour. In this series mixed tumour 
comprised 68.52% of all the parotid tumours and 94.87% of all benign 
tumours. In Foote and Frazxell series it forms 56% of all salivary 
tumours. In this series the maximum number of mixed tumour was found 
in 31-40 years age group which is in concordance with Sireat’s series in 
which the maximum incidence is noted in the 4th decade. 
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TABLE XII 
COMPARTIVE STUDY OF DIFFERENT PAROTID TUMOURS 
IN THE STUDY WITH THE REPORTS OF VARIOUSAUTHORS 
 
S. 
No. 
Type of tumour Thanckaray 
& Lintus 
Toraya 
et al 
Sindha
et al 
Saksela 
et al 
Present 
study 
1 Pleomorphic 
adenoma 
74.0 70.5 60.0 60.4 68.52 
2 Monomorphic 
adenoma 
8.6 12.7 18.5 6.6 3.70 
3 Mucoepidermoid 3.2 2.1 6.8 7.5 12.96 
4 Acinic cell 2.3 - 2.0 1.9 - 
5 Carcinoma 11.9 14.7 12.7 23.6 14.81 
  
 In this study mixed tumour has got a male preponderance ratio of 
2:1. The other studies in the literature showed a female preponderance. 
 
 As regarding the treatment, superficial parotidectomy is the 
accepted modality of treatment if only the superficial lobe is involved. 
Total parotidectomy is required only if both lobes are involved 
Enucleation is not an accepted modality of treatment since in this study 
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showed a high recurrence rate (25%) and a greater risk of injury to the 
facial nerve (50%).  
 
 FNAC has true positive rate 86.9% in diagnosing this condition 
and it must be performed in all cases. No complications were noted 
following this investigation. 
 
ADENOLYMPHOMA 
 In this series, there were only 2 cases (5.12%) in contrast to other 
studies that report a higher incidence of this tumour. Both the patients are 
males which are in accordance to the other studies which showed a male 
predominance. A swelling was the presenting complaint in both cases. 
Soft, cystic parotid swelling (Benign) is almost diagnostic of the 
condition except in confirming that it is a benign swelling. Superficial 
parotidectomy is curative. 
 
MALIGNANT TUMOURS 
 There were 15 cases of malignant tumours in this series. It forms 
27.77% of all neoplasms of the parotid. Among them, Mucoepidermoid 
formed the majority. There was no acinic cell tumour in this series. Out 
of the 15 cases 11 were, males and 4 were females. In this series, 
malignancy was seen after the 4th decade (older age group) 
 
68
 The presence of a mass is the most consistent finding in all cases. 
Malignant pleomorphic adenoma has the same natural history of its 
benign counterpart, but is showed an initial slow growth followed by 
rapid increase in size. Pain was present in 9 patients. Facial nerve was 
involved in 5 patients. Secondary lymph node involvement was present in 
4 cases. Temporomandibular joint was involved in 3 cases. 
 
 Out of 15 cases of period malignancy, radical parotidectomy was 
done for 2 cases, lymph node dissection was done for one patient. For the 
7 cases of Mucoepidermoid carcinoma 3 cases were misdiagnosed as 
pleomorphic adenoma, since FNAC was inconclusive. For these patients 
a superficial parotidectomy was done. Post operative histopathological 
examination revealed the true nature of the lesion. These patients were 
given post operative radio therapy. The remaining 4 patients had a total 
parotidectomy done and no radio therapy was given post operatively. The 
patient with adenoid cystic carcinoma was put on chemotherapy with cis-
platin. The remaining 2 patients were put on chemotherapy since they had 
advance lesions with involvement of temporomandibular joint. In one 
patient debulking parotidectomy was done following neoadjuvant 
chemotherapy and post operative radio therapy was given. 
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                                                Warthin s tumour 
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SUMMARY 
 The clinical findings and histological features of 54 cases of 
parotid gland tumours treated at Govt.Rajaji hospital, Madurai from Oct 
2006 to Oct 2008 were studied. Parotid gland tumours were uncommon 
tumours forming only 0.073% of all cases admitted in the hospital. The 
study illustrates a wide variation in the natural history and degree of 
malignancy of parotid tumours. The clinical features of benign tumours 
had definite bearing on the final histopathological with no complication. 
FNAC is a reliable investigation for benign tumours with no 
complication. FNAC is useful in malignant tumours also, being positive 
in 11 out of 15 cases (73.33%). But FNAC could not provide the 
histopathological type of tumour in most case. So is there a role for Tru-
cut biopsy in these cases doubtful cases. 
 
 For most benign tumours the approved treatment is superficial 
conservative parotidectomy which has been followed in this series. The 
disadvantages of enucleation, namely recurrence and facial nerve injury 
are thus minimized. The facial nerve should be visualized and preserved. 
The risk of nerve does not increase with the extent of the surgical 
procedure as long as the facial nerve is identified and preserved. 
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 Total parotidectomy was done for Mucoepidermoid tumours 
without involvement of the facial nerve. Chemotherapy showed fairly 
good result in adenoid cystic carcinoma providing symptomatic relief and 
reduction in the size of the lesion. It was not much use in the other 
tumours in which it was used. 
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CONCLUSION 
1. Incidence of parotid tumours was 0.074% of all cases admitted to 
Govt.Rajaji hospital, Madurai during the twenty four months of 
study. So they are an uncommon pathology. 
2. Benign tumours form the majority 72.22% of parotid neoplasms 
pleomorphic adenoma being the commonest 68.52% 
3. Superficial lobe was the commonest site for tumour formation. 
4. There was a male preponderance of 2:1in parotid tumours. 
5. Higher incidence of parotid tumour was found in the 4th and 5th 
decades of life. 
6. Mass in the parotid region was the commonest mode of 
presentation of parotid tumours. 
7. The clinical features of benign tumours have a definite bearing on 
the final histopathological diagnosis and are therefore a reliable 
guide for the preoperative diagnosis and treatment of benign 
parotid tumours. 
8. Maximum incidence of pleomorphic adenoma was between 31-40 
years of age with a male preponderance 
9. An asymptomatic lump was the most common mode of 
presentation of pleomorphic adenoma. 
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10. Adenolymphoma showed a 100% male predominance in this study 
with both the cases in the 6th decade. 
11. FNAC is a useful diagnostic tool in the diagnosis of benign parotid 
tumours with virtually no complication. 
12. The study illustrates wide variations in the natural history and 
degree of malignancy of parotid tumours. 
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Final 
diagnosis 
1 Alagu 16 m +        - PA 
2 Bomiraj 20 m +        SP PA 
3 Mustafa 36 m +        SP PA 
4 Shanmugam 37 m +        SP PA 
5 Kavitha 25 f +        - PA 
6 Ganesan 39 m +        SP PA 
7 Arupadai 37 m +        SP PA 
8 Vetrivel 33 m +        SP PA 
9 Mariammal 29 f +        SP PA 
10 Rajakumari 28 f +        SP PA 
12 Karuppaiah 37 m +        SP PA 
13 Lenin 38 m +        SP PA 
14 Arivoli 37 m +        SP PA 
15 Palaniamma 39 f +        - PA 
16 Anbarasan 45 m +        SP PA 
17 Subburaj 46 m +        SP PA 
18 Arbudaraj 42 m +        SP PA 
19 Palani 41 m +        SP PA 
20 Karunanidi 47 m +        SP PA 
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Final 
diagnosis 
21 Mariamma 37 f +        SP PA 
22 Kalirajan 55 m +        SP PA 
23 Nallusamy 54 m +        CTP PA 
24 Siluvai 36 m +        SP PA 
25 Karpagavalli 40 f       +  - AdCC 
26 Thangapandi 63 m +        CTP PA 
27 Sivasamy 36 m +        - PA 
28 Tirutani 66 m +        CTP PA 
29 Pitchaiamal 36 f +        SP PA 
30 Md yusuf 50 m +  + + +    - An.C 
31 Rajappa  m +    +    TP MEC 
32 Mariappan 58 m         SP AL 
33 Guru  m +       PA SP MEC 
34 Nallammal  f +  -  +    - MPA 
35 Santhanam  m         CT AdCC 
36 Erulappan  m   + +     - AC 
37 Natrayan  m +    +    TP MEC 
38 Mookan  m   + + + +   CT AC 
39 Duraisamy  m   +  + +   CT AC 
40 Padinetu 33 m +        - PA 
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Final 
diagnosis 
41 Kamarnisha 45 f +        SP PA 
42 Maria 46 f +        SP PA 
43 Subramani 48 m +        SP PA 
44 Muthulaxmi  f +       PA SP MEC 
45 Dandapani 46 m +        SP PA 
46 Ramachetiar 47 m +        SP PA 
47 Vasuki 55 f +        SP PA 
48 Deivani  f +       PA SP MEC 
49 Rasudevar 52 m +        SP PA 
50 Ponnammal 37 f       + + SP PA 
51 Vellai 62 m         E AL 
52 Paramu  m   + +  +   - MPA 
53 Chinnan  m        DC TP MEC 
54 kutrallam  m        DC TP MEC 
PA-   pleomorpic adenoma                 MPA- malignant pleomorpic adenoma                                        
AL-   adenolymphoma                        MEC- mucoepidermoid carcinoma 
AC-   adeno carcinoma                       AdCC- adenoid cystic carcinoma 
AnC- anaplastic carcinoma                 SP      -Superficial parotidectomy 
TP     -Total parotidectomy                 DC   - Dysplastic changes 
CT    - Chemotherapy                          Fnac – fine needle aspiration cytology 
 
 
